These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30328147)

  • 1. Levodopa-induced dyskinesia in Parkinson disease: Sleep matters.
    Amato N; Manconi M; Möller JC; Sarasso S; Stanzione P; Staedler C; Kaelin-Lang A; Galati S
    Ann Neurol; 2018 Dec; 84(6):905-917. PubMed ID: 30328147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack variation of low slow-wave activity over time in the frontal region in NREM sleep may be associated with dyskinesia in Parkinson's disease.
    Wang YM; Liu JY; Gao F; Xie WY; Chen J; Gu HY; Wang F; Zhong CK; Li K; Zhuang S; Cheng XY; Jin H; Zhang JR; Mao CJ; Liu CF
    CNS Neurosci Ther; 2024 Oct; 30(10):e70058. PubMed ID: 39370848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of an association between sleep and levodopa-induced dyskinesia in an animal model of Parkinson's disease.
    Galati S; Salvadè A; Pace M; Sarasso S; Baracchi F; Bassetti CL; Kaelin-Lang A; Städler C; Stanzione P; Möller JC
    Neurobiol Aging; 2015 Mar; 36(3):1577-89. PubMed ID: 25596726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow wave activity across sleep-night could predict levodopa-induced dyskinesia.
    Amato N; Caverzasio S; Manconi M; Staedler C; Kaelin-Lang A; Galati S
    Sci Rep; 2023 Sep; 13(1):15468. PubMed ID: 37726375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study.
    Nimura T; Ando T; Yamaguchi K; Nakajima T; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2004 Apr; 100(4):606-10. PubMed ID: 15070112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
    Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
    Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia.
    Zhang YH; Tang BS; Song CY; Xu Q; Lou MX; Liu ZH; Yu RH; Yan XX; Guo JF
    Neurosci Lett; 2013 Nov; 556():109-12. PubMed ID: 24135335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
    Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
    Gour J; Edwards R; Lemieux S; Ghassemi M; Jog M; Duval C
    Brain Res Bull; 2007 Sep; 74(1-3):66-74. PubMed ID: 17683791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.
    Hong JY; Oh JS; Lee I; Sunwoo MK; Ham JH; Lee JE; Sohn YH; Kim JS; Lee PH
    Neurology; 2014 May; 82(18):1597-604. PubMed ID: 24719485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.
    Yoo HS; Chung SJ; Lee YH; Lee HS; Ye BS; Sohn YH; Lee PH
    Neurology; 2019 Mar; 92(13):e1468-e1478. PubMed ID: 30796137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
    Barbin L; Leux C; Sauleau P; Meyniel C; Nguyen JM; Pereon Y; Damier P
    Parkinsonism Relat Disord; 2013 Feb; 19(2):165-70. PubMed ID: 23000298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.
    Pahwa R; Tanner CM; Hauser RA; Isaacson SH; Nausieda PA; Truong DD; Agarwal P; Hull KL; Lyons KE; Johnson R; Stempien MJ
    JAMA Neurol; 2017 Aug; 74(8):941-949. PubMed ID: 28604926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients.
    Mao CJ; Yang YP; Chen JP; Wang F; Chen J; Zhang JR; Zhang HJ; Zhuang S; Xiong YT; Gu CC; Yuan W; Huang JY; Fay A; Zhong CK; Liu CF
    Parkinsonism Relat Disord; 2018 Mar; 48():68-73. PubMed ID: 29305084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
    Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
    Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of levodopa-induced complications.
    Aquino CC; Fox SH
    Mov Disord; 2015 Jan; 30(1):80-9. PubMed ID: 25488260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in slow-wave sleep characteristics in Parkinson's disease patients with mild-moderate depression.
    Hu J; Wu J; Jiang Q; Wang Y; Yuan Y; Cheng X; Li K; Shen Y; Zhang J; Wang F; Liu J; Liu C; Dai Y; Mao C
    Sleep Med; 2024 Sep; 121():219-225. PubMed ID: 39004012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.